arbiter
发表于 2025-3-28 18:11:32
http://reply.papertrans.cn/23/2212/221184/221184_41.png
扩大
发表于 2025-3-28 19:27:44
http://reply.papertrans.cn/23/2212/221184/221184_42.png
nuclear-tests
发表于 2025-3-28 23:07:52
Proteomic Profiling of Tyrosine Kinases as Pharmacological Endpoints for Targeted Cancer Therapyions, prediction of clinical outcome and monitoring response to cancer treatments. The exciting move toward kinase-targeted therapy has brought new technical challenges in profiling protein kinase genes and proteins as surrogate clinical biomarkers, particularly in light of clinical data correlating
osteoclasts
发表于 2025-3-29 05:31:52
Oncoproteomics for Personalized Management of Cancer individual. Numerous proteomic technologies are available, and selected ones relevant to development of personalized therapy are described. Cancer biomarkers discovered by proteomics can be used for diagnosis as well as drug targets, thus facilitating the integration of diagnostics and therapeutics
NAVEN
发表于 2025-3-29 09:04:44
Application of Serum and Tissue Proteomics to Understand and Detect Solid Tumorse detailed analysis of a diverse set of proteins and their isoforms at the molecular level. These new, high-throughput, and comprehensive proteomic studies can be useful in advancing our understanding of disease processes and have wide potential for integration within clinical trials. Clinical trial
Euphonious
发表于 2025-3-29 15:07:45
http://reply.papertrans.cn/23/2212/221184/221184_46.png
hauteur
发表于 2025-3-29 18:42:44
http://reply.papertrans.cn/23/2212/221184/221184_47.png